Understanding biosimilars and projecting the cost savings to employers

This study quantifies the impact of biosimilar savings and analyses the potential drivers of cost savings and their variability.

Measuring the strength of the individual mandate

An analysis of the individual mandate’s penalties in relation to the expected out-of-pocket premium for bronze-level coverage in the individual market.

Microinsurance at Milliman

Milliman consultants talk about their involvement with microinsurance projects in the developing world. 

Managed long-term care plans in New York state: Critical factors for financial viability

An analysis of financial feasibility must be based on today’s rules and today’s economic realities—not on past experience.

A look at 2011 year-end financial results for medical professional liability specialty writers

Direct written premium for a composite of medical professional liability (MPL) specialty writers declined, but this group of companies continues to achieve remarkable calendar-year profitability.

An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost

The results of a recent large randomized controlled trial showed that screening with low-dose spiral computed tomography reduces lung cancer mortality.

Healthcare reform in 2012: Blind curves ahead

How the outcomes of the Supreme Court proceedings and the November general election may affect healthcare reform.